208 related articles for article (PubMed ID: 6252831)
41. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Bulger RR; Washington JA
Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575
[TBL] [Abstract][Full Text] [Related]
42. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
43. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
44. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Barza M; Gorbach SL
Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396
[TBL] [Abstract][Full Text] [Related]
45. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Lagast H; Zinner SH; Klastersky J
Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
[TBL] [Abstract][Full Text] [Related]
46. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
48. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Simard P; Bergeron MG
J Antimicrob Chemother; 1982 Nov; 10(5):397-402. PubMed ID: 6294044
[No Abstract] [Full Text] [Related]
49. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
50. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
51. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
52. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of LY127935.
Fass RJ
Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
[TBL] [Abstract][Full Text] [Related]
54. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Greenfield RA; Kurzynski TA; Craig WA
Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
[TBL] [Abstract][Full Text] [Related]
55. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
[No Abstract] [Full Text] [Related]
56. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Pulverer G; Peters G
Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
[No Abstract] [Full Text] [Related]
57. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
58. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Daschner FD; Goerke C; Bassler M; Just M
Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
[TBL] [Abstract][Full Text] [Related]
59. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Moritz VA; Carson PB
J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
[TBL] [Abstract][Full Text] [Related]
60. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
